drugset / Trial / NCT04688008
Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of the study is to evaluate the relative bioavailability of early phase and late phase hetrombopag olamine formulations in healthy Chinese adult subjects under fasting conditions. The secondary objective of the study is to evaluate the safety of hetrombopag olamine in healthy Chinese adult subjects.
Timeline
- Start
- 2020-09-18
- Primary completion
- 2020-10-12
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hetrombopag | Small molecule | 5 mg | Oral |
Indications
No indication recorded.